Tasly Pharma to list biopharma unit in Hong Kong for $1B

Tianjin, China based Tasly Pharmaceutical Group is planning to list its biopharma unit in Hong Kong to raise about $1 bi...

March 5, 2018 | Monday | News
CARsgen receives $60M equity investment for CAR-T research

China based CARsgen Therapeutics, a leading immune-oncology company focusing on the development of CAR-T therapies, has ...

March 2, 2018 | Friday | News
Alibaba Group opens first research institute in Singapore

Chinese e-commerce giant Alibaba has opened its first joint research institute outside China in Singapore, in a collabor...

March 2, 2018 | Friday | News
Novartis cancer chief joins biotech startup as CMO

Early stage Chinese bispecific biotech EpimAb Biotherapeutics has roped in Bin Peng, M.D., Ph.D, as its first chief medi...

February 28, 2018 | Wednesday | News
HKSTP to focus on biotech, AI to drive innovation

Hong Kong Science and Technology Parks Corporation (HKSTP) plans to focus on biotechnology and artificial intelligence a...

February 28, 2018 | Wednesday | News
MabSpace receives FDA Approval for MSB2311

MabSpace is a global biotechnology company focused on discovering and developing innovative antibody therapeutics using ...

February 27, 2018 | Tuesday | News
Alma Lasers gets FDA clearance for its award winning Soprano ICE platform

Alma Lasers, a subsidiary of Sisram Medical Ltd the leading global innovator of laser light-based, radiofrequency and ul...

February 26, 2018 | Monday | News
STA Pharma, Regulus team up for mRNA targeting drugs

A WuXi AppTec group company, STA Pharmaceutical Co., the leading open-access capability and technology platform for smal...

February 23, 2018 | Friday | News
China, Ethopia sign MoU for biotechnology, genomics

Two institutes from Ethiopia and China have signed a memorandum of understanding (MoU) on scientific and technological c...

February 23, 2018 | Friday | News
Tetraphase enters into agreement with Biopharma firm in China

Tetraphase Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing novel antibiotic...

February 22, 2018 | Thursday | News
Mologen signs license deal for China

The biopharmaceutical company Mologen recently announced the signing of a license deal for the Chinese territory and a g...

February 16, 2018 | Friday | News
Harbin Pharma to buy stake in GNC

China’s state-controlled drugmaker Harbin Pharmaceutical Group Holding Co plans to buy an about 40 percent st...

February 15, 2018 | Thursday | News
Michael Glynn joins CANbridge Life Sciences advisory team

Industry veteran, Michael Glynn, has joined CANbridge Life Sciences' advisory team, where he will provide lead...

February 14, 2018 | Wednesday | News
Vivo Capital leads $55 M funding for Innocare

Healthcare investment firm Vivo Capital led the $55 million funding round of Beijing Innocare, a biopharmaceutical compa...

February 12, 2018 | Monday | News
Jason Chen joins as Chairman of Biostage's Board of Directors

US based Biostage Inc., a biotechnology company developing bioengineered organ implants to treat life-threatening condit...

February 12, 2018 | Monday | News
Tsinghua University to invest $276M in Cambridge Biohub

Tsinghua University Holdings (TUS) of Beijing is planning to invest $276 million to build a new biohub in the UK's Cambr...

February 12, 2018 | Monday | News
Rexahn, Haichang collaborate for developing liver cancer treatment

American clinical stage biopharmaceutical company Rexahn Pharmaceuticals, Inc. has entered into collaboration with China...

February 9, 2018 | Friday | News
ProPak Asia with ACIMGA launches "Printech Asia"

Bangkok hosting Asia’s largest event ‘ProPak Asia’ which include the entire food, drink, and pharma pr...

February 8, 2018 | Thursday | News